Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone

Athilakshmi Kannan, Arpita Bhurke, Régine Sitruk‐Ware, Parameswaran Grace Lalitkumar, Kristina Gemzell‐Danielsson, Alistair Williams, Robert N. Taylor, Milan K. Bagchi, Indrani C. Bagchi
In: Reproductive Sciences · 2017 · vol. 25(3) , pp. 320–328 · doi:10.1177/1933719117746764 · PMID:29241443 · W2775098780
article OA: green CC0 ⤵ 6 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06+body, 2026-06-08 ⓘ

Mifepristone suppresses endometrial HAND2 expression, while chronic ulipristal acetate use does not, suggesting differential effects of progesterone receptor modulators on this pathway.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (32)

Cited by (6)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK